Extendicare Stock

Extendicare EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Extendicare (EXE.TO) as of Aug 2, 2026 is 18.17. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 19.81 — a change of -8.25% (lower).

EV/EBIT

18.17

YoY

-8.25%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Extendicare is 2026 18.17 . EV/EBIT (Enterprise Value to EBIT) of Extendicare was 2025 19.81 . It decreases by -8.25% lower compared to the previous year.

The Extendicare EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2019
14.33 base
Jan 1, 2020
7.15 base
Jan 1, 2021
2.50 base
Jan 1, 2022
27.09 base
Jan 1, 2023
11.04 base
Jan 1, 2024
7.88 base
Jan 1, 2025
13.79 base
Jan 1, 2026 (e)
26.84 base
YEARPRICE-TO-EBIT
2026 est 26.84
2025 13.79
2024 7.88
2023 11.04
2022 27.09
2021 2.50
2020 7.15
2019 14.33
2018 14.51
2017 12.25
2016 15.17
2015 10.13
2014 13.61
2013 14.18
2012 7.42
2011 -
2010 -
2009 -
2008 -
2007 -
2006 -
Access this data via the Eulerpool API
Get Free API Key

Extendicare Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Extendicare's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Extendicare's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Extendicare's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Extendicare grows earnings faster than its peers.

Extendicare Stock analysis

What does Extendicare do? Extendicare, Inc. is a Canadian company that has been operating in the healthcare industry for over 50 years. It was founded in 1968 and is headquartered in Markham, Ontario. Translation: Extendicare, Inc. is a Canadian company that has been operating in the healthcare industry for over 50 years. It was founded in 1968 and is headquartered in Markham, Ontario. Extendicare is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Extendicare stock

EV/EBIT (Enterprise Value to EBIT) of Extendicare is 18.17 in 2026.

Access this data via the Eulerpool API
Get Free API Key

Valuation — Extendicare

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueEV/EBITForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Extendicare